T1	Participants 232 241	patients'
T2	Participants 391 403	158 patients
T3	Participants 534 542	Patients
T4	Participants 804 852	22 (27.8%), 42 (53.2%), and 57 (72.2%) patients,
T5	Participants 924 933	patients,
T6	Participants 1080 1090	two groups
